Bei Akademie registrieren
Johnson & Johnson, US4781601046

Johnson & Johnson stock rises pre-market: healthcare company at EUR 230.60

Published on 10/22/2026 at 08:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
The healthcare group develops medicines and medical devices for patients and professionals. At Lang & Schwarz the stock trades pre-market at EUR 230.60 on October 22, 2026, 1.43 percent above the Xetra close of October 21, 2026.

Healthcare business before the open

  • Johnson & Johnson develops medicines and medical devices for healthcare markets.
  • The market context is the S&P 500.
  • Johnson & Johnson stock trades pre-market at EUR 230.60 at 8:02 a.m. CEST at Lang & Schwarz on October 22, 2026, 1.43 percent above the Xetra close of October 21, 2026.
Johnson & Johnson, US4781601046, Illustration mit AI erstellt.
Johnson & Johnson, US4781601046, Illustration mit AI erstellt.

Johnson & Johnson is a healthcare company that develops medicines and medical devices, according to its investor-relations site. At 8:02 a.m. CEST on October 22, 2026, Johnson & Johnson stock trades pre-market at EUR 230.60 at Lang & Schwarz, 1.43 percent above the Xetra close of October 21, 2026 (EUR 227.35).

Ahead of the Xetra open

The indication is EUR 3.25 above the Xetra close. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Johnson & Johnson stock.

The group and its market

Johnson & Johnson's business spans medicines and medical technologies serving patients, healthcare professionals and institutions worldwide, as described by its investor-relations site. Market context: Market report S&P 500.

More news and analysis on Johnson & Johnson stock

Disclaimer...
en | US4781601046 | JOHNSON & JOHNSON | boerse | 70390436 |